During the IPC Annual Conference, held recently in Bratislava, Microbiomepost discussed with Philippe Langella, Research Director at the French National Institute of Agricultural Research (INRA), in France, the potential of Faecalibacterium Prausnitzii as Live Biotherapeutics for several disease, the strategy used to develop this strain and the regulatory approach.
Gut microbiota as a source of Live Biotherapeutics: the F. prausnitzii case history
Philippe Langella, Research Director at the French National Institute of Agricultural Research, discussed the potential of Faecalibacterium Prausnitzii as Live Biotherapeutics for several disease.
Most recent
Gastroenterology
26 April 2024
HCPs Area
Industry
- Read more about gut microbiota, LBP, next generation probiotics, probiotics
Gastroenterology
26 April 2024
